CLAZF

Claritas Pharmaceuticals, Inc. CLAZF

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CLAZF PCNT ELVAY CNBI ERUC HTPRF ALSE RADCQ SLGWF
6M 9 900.00 % 0.00 % 0.00 % 100.00 % 0.00 % 0.00 % 0.00 % -93.33 % -81.88 %
YTD 0.00 % 0.00 % 0.00 % 100.00 % 0.00 % 0.00 % 0.00 % -95.45 % 0.00 %
1Y 0.00 % 0.00 % 0.00 % 100.00 % 0.00 % -89.47 % 0.00 % -98.15 % -85.67 %
3Y -89.80 % -99.62 % 0.00 % 100.00 % 0.00 % -87.80 % -99.86 % -99.93 % -94.64 %
5Y 100.00 % -99.81 % 0.00 % -97.78 % 0.00 % -98.92 % -99.94 % -99.86 % -99.82 %
10Y -99.99 % -99.99 % 0.00 % -98.18 % -99.90 % -99.53 % -99.99 % -99.99 % -99.97 %
From the beginning -99.99 % -99.97 % 0.00 % -99.99 % -100.00 % -99.71 % -100.00 % -99.96 % -99.97 %

Dividend

Evolva Holding S.A.

China BCT Pharmacy Group, Inc.

Rite Aid Corporation